MAIA Biotechnology Inc (MAIA)
3.62
+0.21
(+6.16%)
USD |
NYAM |
May 21, 16:00
3.50
-0.12
(-3.31%)
After-Hours: 20:00
MAIA Biotechnology Free Cash Flow: -13.30M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -13.30M |
December 31, 2023 | -13.07M |
September 30, 2023 | -12.03M |
June 30, 2023 | -13.19M |
March 31, 2023 | -12.65M |
Date | Value |
---|---|
December 31, 2022 | -12.10M |
September 30, 2022 | -10.75M |
June 30, 2022 | -7.746M |
March 31, 2022 | -6.677M |
December 31, 2021 | -4.123M |
Free Cash Flow Range, Past 5 Years
-13.30M
Minimum
Mar 2024
-4.123M
Maximum
Dec 2021
-10.56M
Average
-12.06M
Median
Free Cash Flow Benchmarks
Cyclacel Pharmaceuticals Inc | -9.734M |
Avid Bioservices Inc | -38.50M |
Oragenics Inc | -8.246M |
NeuBase Therapeutics Inc | -14.85M |
Viking Therapeutics Inc | -54.87M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -3.587M |
Cash from Financing (Quarterly) | 4.717M |
Free Cash Flow Per Share (Quarterly) | -0.2038 |
Free Cash Flow Yield | -24.63% |